{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:20:19Z","timestamp":1788546019579,"version":"build-2803163510"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T00:00:00Z","timestamp":1769558400000},"content-version":"vor","delay-in-days":14,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100030902","name":"Martin-Luther-Universit\u00e4t Halle-Wittenberg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100030902","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Resistance to anoikis, a form of programmed cell death that occurs after detachment from the surrounding extracellular matrix, is a prerequisite for the survival of circulating tumor cells (CTCs) in the bloodstream. Platelets can interact with these CTCs and protect them from cytokine- and immune cell-mediated cell death. Whether platelets can regulate anoikis resistance by controlling intrinsic gene expression changes in tumor cells that contribute to metastasis has not been studied in detail in pancreatic cancer cells.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Pancreatic cancer cells were cultured under attached or low-attachment conditions to induce and mimic anoikis. The detached cells were co-cultured with platelets and subsequent gene expression analyses were performed to identify deregulated pathways responsible for survival under detached conditions that are mediated by platelets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We observed a cell line-dependent sensitivity of pancreatic cancer cells to anoikis and that anoikis resistance was greatly enhanced by platelet interaction. RNA sequencing and transcriptome analyses identified FOXM1 as a differentially regulated gene between attached and detached cells, and its expression was modulated by platelets via an activated AKT signaling pathway. Manipulating FOXM1 protein expression via gain- and loss-of-function approaches or by inhibiting its activity using small-molecule inhibitors significantly impacts platelet-influenced death rates. Intriguingly, single-cell RNA sequencing and immunohistochemical analyses revealed higher FOXM1 expression in pancreatic cancer metastases than in primary tumors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Overall, these findings suggest that targeting FOXM1 may be a promising therapeutic strategy to interfere with the metastatic progression of pancreatic cancer, which might particularly benefit patients with high blood platelet counts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-025-02644-8","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:24:03Z","timestamp":1768400643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["FOXM1 regulates platelet-induced anoikis resistance in pancreatic cancer cells"],"prefix":"10.1186","volume":"24","author":[{"given":"Alissa","family":"Ernesti-Soldatkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin T.","family":"Neu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beate","family":"Heydel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferdinand","family":"Krannich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut","family":"Laumen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Gutschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Haemmerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"2644_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"2644_CR2","doi-asserted-by":"publisher","first-page":"16022","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, et al. Pancreatic cancer. Nat Rev Dis Primers. 2016;2:16022.","journal-title":"Nat Rev Dis Primers"},{"key":"2644_CR3","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1016\/j.cell.2023.03.003","volume":"186","author":"S Gerstberger","year":"2023","unstructured":"Gerstberger S, Jiang Q, Ganesh K. Metastasis. Cell. 2023;186:1564\u201379.","journal-title":"Cell"},{"key":"2644_CR4","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1083\/jcb.124.4.619","volume":"124","author":"SM Frisch","year":"1994","unstructured":"Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994;124:619\u201326.","journal-title":"J Cell Biol"},{"key":"2644_CR5","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1158\/2159-8290.CD-12-0329","volume":"2","author":"M Labelle","year":"2012","unstructured":"Labelle M, Hynes RO. The initial hours of metastasis: the importance of cooperative host-tumor cell interactions during hematogenous dissemination. Cancer Discov. 2012;2:1091\u20139.","journal-title":"Cancer Discov"},{"key":"2644_CR6","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41467-017-00411-z","volume":"8","author":"M Haemmerle","year":"2017","unstructured":"Haemmerle M, Taylor ML, Gutschner T, Pradeep S, Cho MS, Sheng J, et al. Platelets reduce anoikis and promote metastasis by activating YAP1 signaling. Nat Commun. 2017;8:310.","journal-title":"Nat Commun"},{"key":"2644_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.ccr.2011.09.009","volume":"20","author":"M Labelle","year":"2011","unstructured":"Labelle M, Begum S, Hynes RO. Direct signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasis. Cancer Cell. 2011;20:576\u201390.","journal-title":"Cancer Cell"},{"key":"2644_CR8","first-page":"395","volume":"72","author":"MR Vila","year":"1995","unstructured":"Vila MR, Lloreta J, Schussler MH, Berrozpe G, Welt S, Real FX. New pancreas cancers cell lines that represent distinct stages of ductal differentiation. Lab Invest. 1995;72:395\u2013404.","journal-title":"Lab Invest"},{"key":"2644_CR9","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2018.01.021","volume":"33","author":"PK Ng","year":"2018","unstructured":"Ng PK, Li J, Jeong KJ, Shao S, Chen H, Tsang YH, et al. Systematic functional annotation of somatic mutations in cancer. Cancer Cell. 2018;33:450\u201362. e10.","journal-title":"Cancer Cell"},{"key":"2644_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.diff.2020.08.002","volume":"115","author":"L Moparthi","year":"2020","unstructured":"Moparthi L, Koch S. A uniform expression library for the exploration of FOX transcription factor biology. Differentiation. 2020;115:30\u20136.","journal-title":"Differentiation"},{"key":"2644_CR11","doi-asserted-by":"crossref","unstructured":"Dorn A, Glass M, Neu CT, Heydel B, Huttelmaier S, Gutschner T et al. LINC00261 is differentially expressed in pancreatic cancer subtypes and regulates a Pro-Epithelial cell identity. Cancers (Basel). 2020;12(8):2077.","DOI":"10.3390\/cancers12051227"},{"key":"2644_CR12","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet. 2003;34:267\u201373.","journal-title":"Nat Genet"},{"key":"2644_CR13","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2644_CR14","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51:D638\u201346.","journal-title":"Nucleic Acids Res"},{"key":"2644_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531:47\u201352.","journal-title":"Nature"},{"key":"2644_CR16","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","volume":"32","author":"Cancer Genome Atlas Research Network","year":"2017","unstructured":"Cancer Genome Atlas Research Network. Electronic address aadhe, cancer genome atlas research N. Integrated genomic characterization of pancreatic ductal adenocarcinoma. Cancer Cell. 2017;32:185\u2013203. e13.","journal-title":"Cancer Cell"},{"key":"2644_CR17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s41467-023-36296-4","volume":"14","author":"G Werba","year":"2023","unstructured":"Werba G, Weissinger D, Kawaler EA, Zhao E, Kalfakakou D, Dhara S, et al. Single-cell RNA sequencing reveals the effects of chemotherapy on human pancreatic adenocarcinoma and its tumor microenvironment. Nat Commun. 2023;14:797.","journal-title":"Nat Commun"},{"key":"2644_CR18","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42:293\u2013304.","journal-title":"Nat Biotechnol"},{"key":"2644_CR19","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.1","volume":"10","author":"PL Germain","year":"2021","unstructured":"Germain PL, Lun A, Garcia Meixide C, Macnair W, Robinson MD. Doublet identification in single-cell sequencing data using ScDblFinder. F1000Res. 2021;10:979.","journal-title":"F1000Res"},{"key":"2644_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister C, Satija R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 2019;20:296.","journal-title":"Genome Biol"},{"key":"2644_CR21","unstructured":"Tickle T, Tirosh I, Georgescu C, Brown M, Haas B. InferCNV of the trinity CTAT Project. Klarman cell observatory. Broad Institute of MIT and Harvard; 2019. https:\/\/github.com\/broadinstitute\/inferCNV."},{"key":"2644_CR22","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider CA, Rasband WS, Eliceiri KW. NIH image to imageJ: 25 years of image analysis. Nat Methods. 2012;9:671\u20135.","journal-title":"Nat Methods"},{"key":"2644_CR23","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/ncb1217","volume":"7","author":"J Laoukili","year":"2005","unstructured":"Laoukili J, Kooistra MR, Bras A, Kauw J, Kerkhoven RM, Morrison A, et al. FoxM1 is required for execution of the mitotic programme and chromosome stability. Nat Cell Biol. 2005;7:126\u201336.","journal-title":"Nat Cell Biol"},{"key":"2644_CR24","doi-asserted-by":"publisher","first-page":"10875","DOI":"10.1128\/MCB.25.24.10875-10894.2005","volume":"25","author":"IC Wang","year":"2005","unstructured":"Wang IC, Chen YJ, Hughes D, Petrovic V, Major ML, Park HJ, et al. Forkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase. Mol Cell Biol. 2005;25:10875\u201394.","journal-title":"Mol Cell Biol"},{"key":"2644_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113478","volume":"9","author":"F Zhao","year":"2014","unstructured":"Zhao F, Siu MK, Jiang L, Tam KF, Ngan HY, Le XF, et al. Overexpression of forkhead box protein M1 (FOXM1) in ovarian cancer correlates with poor patient survival and contributes to paclitaxel resistance. PLoS One. 2014;9:e113478.","journal-title":"PLoS One"},{"key":"2644_CR26","doi-asserted-by":"publisher","first-page":"e22734","DOI":"10.1016\/j.heliyon.2023.e22734","volume":"9","author":"K Fang","year":"2023","unstructured":"Fang K, Gong M, Liu D, Liang S, Li Y, Sang W, et al. FOXM1\/KIF20A axis promotes clear cell renal cell carcinoma progression via regulating EMT signaling and affects immunotherapy response. Heliyon. 2023;9:e22734.","journal-title":"Heliyon"},{"key":"2644_CR27","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s13046-019-1202-3","volume":"38","author":"G Hu","year":"2019","unstructured":"Hu G, Yan Z, Zhang C, Cheng M, Yan Y, Wang Y, et al. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression. J Exp Clin Cancer Res. 2019;38:188.","journal-title":"J Exp Clin Cancer Res"},{"key":"2644_CR28","doi-asserted-by":"publisher","first-page":"3672","DOI":"10.1016\/j.celrep.2018.03.013","volume":"22","author":"HN Vasudevan","year":"2018","unstructured":"Vasudevan HN, Braunstein SE, Phillips JJ, Pekmezci M, Tomlin BA, Wu A, et al. Comprehensive molecular profiling identifies FOXM1 as a key transcription factor for meningioma proliferation. Cell Rep. 2018;22:3672\u201383.","journal-title":"Cell Rep"},{"key":"2644_CR29","doi-asserted-by":"publisher","first-page":"13241","DOI":"10.18632\/oncotarget.3676","volume":"6","author":"Q Xie","year":"2015","unstructured":"Xie Q, Wu Q, Mack SC, Yang K, Kim L, Hubert CG, et al. CDC20 maintains tumor initiating cells. Oncotarget. 2015;6:13241\u201354.","journal-title":"Oncotarget"},{"key":"2644_CR30","doi-asserted-by":"publisher","first-page":"5165","DOI":"10.1038\/ncomms6165","volume":"5","author":"MV Gormally","year":"2014","unstructured":"Gormally MV, Dexheimer TS, Marsico G, Sanders DA, Lowe C, Matak-Vinkovic D, et al. Suppression of the FOXM1 transcriptional programme via novel small molecule Inhibition. Nat Commun. 2014;5:5165.","journal-title":"Nat Commun"},{"key":"2644_CR31","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nchem.1114","volume":"3","author":"NS Hegde","year":"2011","unstructured":"Hegde NS, Sanders DA, Rodriguez R, Balasubramanian S. The transcription factor FOXM1 is a cellular target of the natural product thiostrepton. Nat Chem. 2011;3:725\u201331.","journal-title":"Nat Chem"},{"key":"2644_CR32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrc1609","volume":"5","author":"NE Hynes","year":"2005","unstructured":"Hynes NE, Lane HA. ERBB receptors and cancer: the complexity of targeted inhibitors. Nat Rev Cancer. 2005;5:341\u201354.","journal-title":"Nat Rev Cancer"},{"key":"2644_CR33","doi-asserted-by":"publisher","first-page":"115210","DOI":"10.1016\/j.celrep.2024.115210","volume":"44","author":"P Luo","year":"2025","unstructured":"Luo P, Hong H, Zhang B, Li J, Zhang S, Yue C, et al. ERBB4 selectively amplifies TGF-beta pro-metastatic responses. Cell Rep. 2025;44:115210.","journal-title":"Cell Rep"},{"key":"2644_CR34","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/cam4.156","volume":"2","author":"K Nagano","year":"2013","unstructured":"Nagano K, Kanasaki S, Yamashita T, Maeda Y, Inoue M, Higashisaka K, et al. Expression of Eph receptor A10 is correlated with lymph node metastasis and stage progression in breast cancer patients. Cancer Med. 2013;2:972\u20137.","journal-title":"Cancer Med"},{"key":"2644_CR35","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nrc2894","volume":"10","author":"H Huang","year":"2010","unstructured":"Huang H, Bhat A, Woodnutt G, Lappe R. Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer. 2010;10:575\u201385.","journal-title":"Nat Rev Cancer"},{"key":"2644_CR36","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41568-023-00634-x","volume":"24","author":"EB Pasquale","year":"2024","unstructured":"Pasquale EB. Eph receptors and Ephrins in cancer progression. Nat Rev Cancer. 2024;24:5\u201327.","journal-title":"Nat Rev Cancer"},{"key":"2644_CR37","doi-asserted-by":"publisher","first-page":"5554","DOI":"10.1158\/0008-5472.CAN-19-3717","volume":"80","author":"D Parashar","year":"2020","unstructured":"Parashar D, Nair B, Geethadevi A, George J, Nair A, Tsaih SW, et al. Peritoneal spread of ovarian cancer harbors therapeutic vulnerabilities regulated by FOXM1 and EGFR\/ERBB2 signaling. Cancer Res. 2020;80:5554\u201368.","journal-title":"Cancer Res"},{"key":"2644_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119114","volume":"271","author":"M Detarya","year":"2021","unstructured":"Detarya M, Thaenkaew S, Seubwai W, Indramanee S, Phoomak C, Saengboonmee C, et al. High glucose upregulates FOXM1 expression via EGFR\/STAT3 dependent activation to promote progression of cholangiocarcinoma. Life Sci. 2021;271:119114.","journal-title":"Life Sci"},{"key":"2644_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6:425.","journal-title":"Signal Transduct Target Ther"},{"key":"2644_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnves.2025.100046","author":"F Meng","year":"2025","unstructured":"Meng F, Li H, Wang Y, Zheng Z, Chen Y. The mechanism of AKT activation in cancer. Cell Invest. 2025. https:\/\/doi.org\/10.1016\/j.clnves.2025.100046.","journal-title":"Cell Invest"},{"key":"2644_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12964-018-0266-6","volume":"16","author":"GB Liao","year":"2018","unstructured":"Liao GB, Li XZ, Zeng S, Liu C, Yang SM, Yang L, et al. Regulation of the master regulator FOXM1 in cancer. Cell Commun Signal. 2018;16:57.","journal-title":"Cell Commun Signal"},{"key":"2644_CR42","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.semcancer.2017.11.018","volume":"50","author":"S Yao","year":"2018","unstructured":"Yao S, Fan LY, Lam EW. The FOXO3-FOXM1 axis: a key cancer drug target and a modulator of cancer drug resistance. Semin Cancer Biol. 2018;50:77\u201389.","journal-title":"Semin Cancer Biol"},{"key":"2644_CR43","doi-asserted-by":"publisher","first-page":"4329","DOI":"10.1158\/0008-5472.CAN-11-0640","volume":"71","author":"P Raychaudhuri","year":"2011","unstructured":"Raychaudhuri P, Park HJ. FoxM1: a master regulator of tumor metastasis. Cancer Res. 2011;71:4329\u201333.","journal-title":"Cancer Res"},{"key":"2644_CR44","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41419-024-06767-7","volume":"15","author":"C Battistini","year":"2024","unstructured":"Battistini C, Kenny HA, Zambuto M, Nieddu V, Melocchi V, Decio A, et al. Tumor microenvironment-induced FOXM1 regulates ovarian cancer stemness. Cell Death Dis. 2024;15:370.","journal-title":"Cell Death Dis"},{"key":"2644_CR45","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1126\/science.1203543","volume":"331","author":"CL Chaffer","year":"2011","unstructured":"Chaffer CL, Weinberg RA. A perspective on cancer cell metastasis. Science. 2011;331:1559\u201364.","journal-title":"Science"},{"key":"2644_CR46","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2644_CR47","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ccr.2013.05.008","volume":"24","author":"D Schumacher","year":"2013","unstructured":"Schumacher D, Strilic B, Sivaraj KK, Wettschureck N, Offermanns S. Platelet-derived nucleotides promote tumor-cell transendothelial migration and metastasis via P2Y2 receptor. Cancer Cell. 2013;24:130\u20137.","journal-title":"Cancer Cell"},{"key":"2644_CR48","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone RL, Nick AM, McNeish IA, Balkwill F, Han HD, Bottsford-Miller J, et al. Paraneoplastic thrombocytosis in ovarian cancer. N Engl J Med. 2012;366:610\u20138.","journal-title":"N Engl J Med"},{"key":"2644_CR49","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1172\/JCI85086","volume":"126","author":"M Haemmerle","year":"2016","unstructured":"Haemmerle M, Bottsford-Miller J, Pradeep S, Taylor ML, Choi HJ, Hansen JM, et al. FAK regulates platelet extravasation and tumor growth after antiangiogenic therapy withdrawal. J Clin Invest. 2016;126:1885\u201396.","journal-title":"J Clin Invest"},{"key":"2644_CR50","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1182\/blood-2008-06-159541","volume":"113","author":"GL Klement","year":"2009","unstructured":"Klement GL, Yip TT, Cassiola F, Kikuchi L, Cervi D, Podust V, et al. Platelets actively sequester angiogenesis regulators. Blood. 2009;113:2835\u201342.","journal-title":"Blood"},{"key":"2644_CR51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.tmrv.2020.09.005","volume":"34","author":"A Maouia","year":"2020","unstructured":"Maouia A, Rebetz J, Kapur R, Semple JW. The immune nature of platelets revisited. Transfus Med Rev. 2020;34:209\u201320.","journal-title":"Transfus Med Rev"},{"key":"2644_CR52","doi-asserted-by":"publisher","first-page":"E3053","DOI":"10.1073\/pnas.1411082111","volume":"111","author":"M Labelle","year":"2014","unstructured":"Labelle M, Begum S, Hynes RO. Platelets guide the formation of early metastatic niches. Proc Natl Acad Sci U S A. 2014;111:E3053\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2644_CR53","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.pan.2024.08.005","volume":"24","author":"GR Buckland","year":"2024","unstructured":"Buckland GR, Wilding SA, McDonnell D, Hamady ZZR. The role of aspirin in the prevention of pancreatic cancer: a nested case-control study in the UK biobank. Pancreatology. 2024;24:947\u201353.","journal-title":"Pancreatology"},{"key":"2644_CR54","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12893-021-01083-9","volume":"21","author":"E Pretzsch","year":"2021","unstructured":"Pretzsch E, D\u2019Haese JG, Renz B, Ilmer M, Schiergens T, Miksch RC, et al. Effect of platelet inhibition with perioperative aspirin on survival in patients undergoing curative resection for pancreatic cancer: a propensity score matched analysis. BMC Surg. 2021;21:98.","journal-title":"BMC Surg"},{"key":"2644_CR55","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1158\/0008-5472.CAN-19-0762","volume":"79","author":"LM Lichtenberger","year":"2019","unstructured":"Lichtenberger LM, Vijayan KV. Are platelets the primary target of aspirin\u2019s remarkable anticancer activity? Cancer Res. 2019;79:3820\u20133.","journal-title":"Cancer Res"},{"key":"2644_CR56","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.626836","volume":"10","author":"D Kalathil","year":"2020","unstructured":"Kalathil D, John S, Nair AS. FOXM1 and cancer: faulty cellular signaling derails homeostasis. Front Oncol. 2020;10:626836.","journal-title":"Front Oncol"},{"key":"2644_CR57","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/nrc2223","volume":"7","author":"SS Myatt","year":"2007","unstructured":"Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 2007;7:847\u201359.","journal-title":"Nat Rev Cancer"},{"key":"2644_CR58","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/B978-0-12-407173-5.00004-2","volume":"118","author":"I Wierstra","year":"2013","unstructured":"Wierstra I. The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles. Adv Cancer Res. 2013;118:97\u2013398.","journal-title":"Adv Cancer Res"},{"key":"2644_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16213684","author":"R Oktriani","year":"2024","unstructured":"Oktriani R, Pirona AC, Kalmar L, Rahadian AS, Miao B, Bauer AS, et al. Genome-wide CRISPR screen identifies genes involved in metastasis of pancreatic ductal adenocarcinoma. Cancers (Basel). 2024. https:\/\/doi.org\/10.3390\/cancers16213684.","journal-title":"Cancers (Basel)"},{"key":"2644_CR60","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1158\/1078-0432.CCR-13-2311","volume":"20","author":"C Huang","year":"2014","unstructured":"Huang C, Xie D, Cui J, Li Q, Gao Y, Xie K. FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system. Clin Cancer Res. 2014;20:1477\u201388.","journal-title":"Clin Cancer Res"},{"key":"2644_CR61","doi-asserted-by":"crossref","unstructured":"Li L, Li Z, Kong X, Xie D, Jia Z, Jiang W et al. Down-regulation of microRNA-494 via loss of SMAD4 increases FOXM1 and beta-catenin signaling in pancreatic ductal adenocarcinoma cells. Gastroenterology. 2014;147:485\u201397 e18.","DOI":"10.1053\/j.gastro.2014.04.048"},{"key":"2644_CR62","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1093\/emboj\/16.10.2783","volume":"16","author":"A Khwaja","year":"1997","unstructured":"Khwaja A, Rodriguez-Viciana P, Wennstrom S, Warne PH, Downward J. Matrix adhesion and Ras transformation both activate a phosphoinositide 3-OH kinase and protein kinase B\/Akt cellular survival pathway. EMBO J. 1997;16:2783\u201393.","journal-title":"EMBO J"},{"key":"2644_CR63","doi-asserted-by":"crossref","unstructured":"Connor AA, Denroche RE, Jang GH, Lemire M, Zhang A, Chan-Seng-Yue M et al. Integration of genomic and transcriptional features in pancreatic cancer reveals increased cell cycle progression in metastases. Cancer Cell. 2019;35:267\u201382 e7.","DOI":"10.1016\/j.ccell.2018.12.010"},{"key":"2644_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/genes16010056","author":"D Pozzobon","year":"2025","unstructured":"Pozzobon D, Bellezza A, Giorgi FM. Pan-cancer upregulation of the FOXM1 transcription factor. Genes. 2025. https:\/\/doi.org\/10.3390\/genes16010056.","journal-title":"Genes"},{"key":"2644_CR65","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41420-021-00663-1","volume":"7","author":"Q Xu","year":"2021","unstructured":"Xu Q, Chen S, Hu Y, Huang W. Single-cell RNA transcriptome reveals the intra-tumoral heterogeneity and regulators underlying tumor progression in metastatic pancreatic ductal adenocarcinoma. Cell Death Discov. 2021;7:331.","journal-title":"Cell Death Discov"},{"key":"2644_CR66","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1038\/s41467-020-17150-3","volume":"11","author":"JW Franses","year":"2020","unstructured":"Franses JW, Philipp J, Missios P, Bhan I, Liu A, Yashaswini C, et al. Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target. Nat Commun. 2020;11:3303.","journal-title":"Nat Commun"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02644-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02644-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02644-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T06:02:17Z","timestamp":1769580137000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-025-02644-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2644"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02644-8","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"20 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}